Utilising Novel GEMMs to Study Anti-Tumour Mechanisms of Prokarium’s ZH9 Immunotherapy Platform
Time: 3:30 pm
day: Conference Day 1
Details:
- Introducing Prokarium’s product and goals of the platform
- Evaluating the right models for more advanced diseases
- Exploring the use of GEMMs to study bladder cancer
